Evidence map›Paper›PMID 37512495›Full record

ArticleMetabolites2023

Genome-Scale Metabolic Reconstruction, Non-Targeted LC-QTOF-MS Based Metabolomics Data, and Evaluation of Anticancer Activity of

Fidias D González Camargo, Mary Santamaria-Torres, Mónica P Cala, Marcela Guevara-Suarez, Silvia Restrepo Restrepo, Andrea Sánchez-Camargo, Miguel Fernández-Niño, María Corujo, Ada Carolina Gallo Molina, Javier Cifuentes and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Plant Metabolomics: The Future of Anticancer Drug Discovery.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Fidias D González CamargoGroup of Product and Process Design, Department of Chemical and Food Engineering, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0009-0002-0660-6540
Mary Santamaria-TorresMetabolomics Core Facility-MetCore Vice-Presidency for Research and Creation, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0009-0008-9136-9626
Mónica P CalaMetabolomics Core Facility-MetCore Vice-Presidency for Research and Creation, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0000-0002-8198-726X
Marcela Guevara-SuarezApplied Genomics Research Group Vice-Presidency for Research and Creation, Universidad de los Andes, Bogotá 111711, Colombia.
Silvia Restrepo RestrepoLaboratory of Mycology and Phytopathology (LAMFU), Department of Biological Sciences and Department of Chemical and Food Engineering, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0000-0001-9016-1040
Andrea Sánchez-CamargoGroup of Product and Process Design, Department of Chemical and Food Engineering, Universidad de los Andes, Bogotá 111711, Colombia.
Miguel Fernández-NiñoLeibniz-Institute of Plant Biochemistry, Department of Bioorganic Chemistry, Weinberg 3, 06110 Halle, Germany.ORCID 0000-0002-8231-7989
María CorujoEcomedics S.A.S., Commercially Known as Clever Leaves, Calle 95 # 11A-94, Bogota 110221, Colombia.
Ada Carolina Gallo MolinaChemical and Biochemical Processes Group, Department of Chemical and Environmental Engineering, National University of Colombia, Bogotá 11001, Colombia.
Javier CifuentesResearch Group on Nanobiomaterials, Cell Engineering and Bioprinting (GINIB), Department of Biomedical Engineering, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0000-0003-0916-3909
Julian A SernaResearch Group on Nanobiomaterials, Cell Engineering and Bioprinting (GINIB), Department of Biomedical Engineering, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0000-0002-8298-9179
Juan C CruzResearch Group on Nanobiomaterials, Cell Engineering and Bioprinting (GINIB), Department of Biomedical Engineering, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0000-0002-7790-7546
Carolina Muñoz-CamargoResearch Group on Nanobiomaterials, Cell Engineering and Bioprinting (GINIB), Department of Biomedical Engineering, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0000-0001-6238-9021
Andrés F Gonzalez BarriosGroup of Product and Process Design, Department of Chemical and Food Engineering, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0000-0003-2517-2020
Universidad de Los Andes · COLeibniz Institute of Plant Biochemistry · DEUniversidad Nacional de Colombia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past decades, Colombia has suffered complex social problems related to illicit crops, including forced displacement, violence, and environmental damage, among other consequences for vulnerable populations. Considerable effort has been made in the regulation of illicit crops, predominantly

Indexed as

anticancer activityCannabis sativametabolomic validationplant genome-scale metabolic reconstructionsecondary metabolism

Identifiers

PMID37512495
PMCPMC10385671
OpenAlexW4382133764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.